Quality of care and mortality are worse in chronic kidney disease patients living in remote areas

Kidney International

Volumn 79, Issue 2, 2011, Pages 210-217

  Rucker, Diana ^a   Hemmelgarn, Brenda R ^b   Lin, Meng ^a   Manns, Braden J ^b   Klarenbach, Scott W ^a   Ayyalasomayajula, Bharati ^a   James, Matthew T ^b   Bello, Aminu ^a   Gordon, Deb ^c   Jindal, Kailash K ^a   Tonelli, Marcello ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

Author keywords

ACE inhibitors; chronic kidney disease; glomerular filtration rate; hospitalization; mortality

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROLOGIST; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEINURIA; RURAL HEALTH CARE; TREATMENT OUTCOME; URINE LEVEL;

EID: 78650869903     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.376     Document Type: Article

References (30)

1. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. JASN 2006;17: 2034-2047.
2. Tonelli M, Klarenbach S, Manns B et al. Residence location and likelihood of kidney transplantation. CMAJ 2006;175: 478-482.
3. Tonelli M, Hemmelgarn B, Culleton B et al. Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int 2007; 72:1023-1028.
4. Dansky KH, Dirani R. The use of health care services by people with diabetes in rural areas. J Rural Health1998;14:129-137.
5. Casey MM, Thiede Call K, Klingner JM. Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med 2001; 21:182-188.
6. James P, Wysong JA, Rosenthal T et al. Access to care in regionalized health care systems. JAMA1996; 275: 758-759.
7. Muntner P, He J, Hamm L et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. JASN 2002;13: 745-753.
8. Owen Jr WF. Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. JASN 2003;14: S76-S80.
9. Reddan D, Klassen P, Frankenfield DL et al. National profile of practice patterns for hemodialysis vascular access in the United States. JASN 2002;13: 2117-2124.
10. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
11. de Zeeuw D, Lewis EJ, Remuzzi G et al. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 2006; 367: 899-900; author reply 900-2.
12. Strippoli GF, Craig M, Deeks JJ et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004; 329: 828.
13. Tonelli M, Isles C, Craven T et al. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation 2005;112:171-178.
14. Tonelli M, Isles C, Curhan GC et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 2004;110:1557-1563.
15. Ifudu O, Dawood M, Homel P et al. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis1996; 28: 841-845. (Pubitemid 26412079)
16. Tonelli M, Klarenbach S, Rose C et al. Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States. JAMA 2009; 301:1681-1690.
17. Tonelli M, Manns B, Culleton B et al. Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysis. CMAJ 2007;177:1039-1044.
18. Fan ZJ, Lackland DT, Lipsitz SR et al. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place 2007;13:179-187.
19. Andreasyan K, Hoy WE. Renal-related deaths in Indigenous people in Queensland, Australia. Nephrology 2007;12: 514-519.
20. Smith KB, Humphreys JS, Wilson MG. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health 2008;16: 56-66.
21. Starfield B. Promoting equity in health through research and understanding. Dev World Bioeth 2004; 4: 76-95.
22. Hemmelgarn BR, Clement F, Manns BJ et al. Overview of the Alberta kidney disease network. BMC Nephrol 2009;10: 30.
23. Quan H, Sundararajan V, Halfon P et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 2005; 43:1130-1139.
24. Levin A, Hemmelgarn B, Culleton B et al. Guidelines for the management of chronic kidney disease. CMAJ 2008;179:1154-1162.
25. Meltzer S, Leiter L, Daneman D et al.1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ1998;159(Suppl 8): S1-29.
26. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensinconverting- enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med1993; 329:1456-1462.
27. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
28. Wright Jr JT, Bakris G, Greene T et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288: 2421-2431.
29. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349: 1857-1863.
30. Curtis BM, Ravani P, Malberti F et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20:147-154.